SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-026618
Filing Date
2015-03-16
Accepted
2015-03-16 18:00:01
Documents
2
Period of Report
2015-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4401
2 POA DOCUMENT poa.txt EX-24.3_571314 3698
  Complete submission text file 0001209191-15-026618.txt   9536
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
Sofia Michael J. (Reporting) CIK: 0001635324 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 15704334